Literature DB >> 19646493

Electrospun materials as potential platforms for bone tissue engineering.

Jun-Hyeog Jang1, Oscar Castano, Hae-Won Kim.   

Abstract

Nanofibrous materials produced by electrospinning processes have attracted considerable interest in tissue regeneration, including bone reconstruction. A range of novel materials and processing tools have been developed to mimic the native bone extracellular matrix for potential applications as tissue engineering scaffolds and ultimately to restore degenerated functions of the bone. Degradable polymers, bioactive inorganics and their nanocomposites/hybrids nanofibers with suitable mechanical properties and bone bioactivity for osteoblasts and progenitor/stem cells have been produced. The surface functionalization with apatite minerals and proteins/peptides as well as drug encapsulation within the nanofibers is a promising strategy for achieving therapeutic functions with nanofibrous materials. Recent attempts to endow a 3D scaffolding technique to the electrospinning regime have shown some promise for engineering 3D tissue constructs. With the improvement in knowledge and techniques of bone-targeted nanofibrous matrices, bone tissue engineering is expected to be realized in the near future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19646493     DOI: 10.1016/j.addr.2009.07.008

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  73 in total

1.  Elastomeric polypeptide-based biomaterials.

Authors:  Linqing Li; Manoj B Charati; Kristi L Kiick
Journal:  J Polym Sci A Polym Chem       Date:  2010-10       Impact factor: 2.702

Review 2.  Vascularized bone tissue engineering: approaches for potential improvement.

Authors:  Lonnissa H Nguyen; Nasim Annabi; Mehdi Nikkhah; Hojae Bae; Loïc Binan; Sangwon Park; Yunqing Kang; Yunzhi Yang; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2012-09-04       Impact factor: 6.389

Review 3.  Next generation of electrosprayed fibers for tissue regeneration.

Authors:  Jong Kyu Hong; Sundararajan V Madihally
Journal:  Tissue Eng Part B Rev       Date:  2011-02-20       Impact factor: 6.389

4.  Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain.

Authors:  Bonnie K Culpepper; Matthew C Phipps; Paul P Bonvallet; Susan L Bellis
Journal:  Biomaterials       Date:  2010-10-28       Impact factor: 12.479

5.  Improved cellular infiltration in electrospun fiber via engineered porosity.

Authors:  Jin Nam; Yan Huang; Sudha Agarwal; John Lannutti
Journal:  Tissue Eng       Date:  2007-09

6.  Hierarchically engineered fibrous scaffolds for bone regeneration.

Authors:  Nadège Sachot; Oscar Castaño; Miguel A Mateos-Timoneda; Elisabeth Engel; Josep A Planell
Journal:  J R Soc Interface       Date:  2013-08-28       Impact factor: 4.118

7.  From design of bio-based biocomposite electrospun scaffolds to osteogenic differentiation of human mesenchymal stromal cells.

Authors:  Julien Ramier; Daniel Grande; Thibault Bouderlique; Olya Stoilova; Nevena Manolova; Iliya Rashkov; Valérie Langlois; Patricia Albanese; Estelle Renard
Journal:  J Mater Sci Mater Med       Date:  2014-03-02       Impact factor: 3.896

8.  Engineering the microstructure of electrospun fibrous scaffolds by microtopography.

Authors:  Qian Cheng; Benjamin L-P Lee; Kyriakos Komvopoulos; Song Li
Journal:  Biomacromolecules       Date:  2013-04-25       Impact factor: 6.988

9.  Effect of surfactant types on the biocompatibility of electrospun HAp/PHBV composite nanofibers.

Authors:  A Suslu; A Z Albayrak; A S Urkmez; E Bayir; U Cocen
Journal:  J Mater Sci Mater Med       Date:  2014-08-05       Impact factor: 3.896

10.  Synovial stem cells and their responses to the porosity of microfibrous scaffold.

Authors:  Benjamin Li-Ping Lee; Zhenyu Tang; Aijun Wang; Fang Huang; Zhiqiang Yan; Dong Wang; Julia S Chu; Neerav Dixit; Li Yang; Song Li
Journal:  Acta Biomater       Date:  2013-03-19       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.